Baker Bros. Advisors’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.5M Buy
2,585,978
+352,879
+16% +$3.57M 0.16% 44
2025
Q4
$20.9M Buy
2,233,099
+520,217
+30% +$4.07M 0.12% 51
2025
Q3
$12.9M Hold
1,712,882
0.09% 60
2025
Q2
$5.77M Sell
1,712,882
-30,843
-2% -$115K 0.06% 64
2025
Q1
$6.73M Hold
1,743,725
0.07% 55
2024
Q4
$10.8M Hold
1,743,725
0.11% 52
2024
Q3
$9.38M Buy
1,743,725
+48,431
+3% +$228K 0.1% 54
2024
Q2
$5.68M Buy
1,695,294
+33,174
+2% +$129K 0.07% 60
2024
Q1
$6.7M Buy
1,662,120
+162,120
+11% +$433K 0.08% 59
2023
Q4
$3.98M Hold
1,500,000
0.05% 64
2023
Q3
$3.54M Buy
1,500,000
+1,000,000
+200% +$4.66M 0.02% 73
2023
Q2
$3.15M Sell
500,000
-126,884
-20% -$776K 0.02% 86
2023
Q1
$3.62M Sell
626,884
-65,247
-9% -$488K 0.02% 77
2022
Q4
$7.1M Sell
692,131
-744,505
-52% -$10.1M 0.04% 69
2022
Q3
$24M Hold
1,436,636
0.16% 41
2022
Q2
$20.1M Hold
1,436,636
0.11% 48
2022
Q1
$23.2M Hold
1,436,636
0.13% 48
2021
Q4
$30.8M Hold
1,436,636
0.15% 46
2021
Q3
$21.1M Hold
1,436,636
0.09% 61
2021
Q2
$28.6M Hold
1,436,636
0.13% 57
2021
Q1
$43M Buy
+1,436,636
New +$48.5M 0.19% 43

Other funds holding DSGN